HomePharma

Pharma

Pharma

BeiGene Announces Approval in Canada of BRUKINSA® (Zanubrutinib)

Life Sciences Times - 0
Pharma

Lineage’s OPC1 Cell Therapy for the Treatment of Spinal Cord Injury to Return to Clinical Testing

Life Sciences Times - 0
Pharma

PolarityTE Submits Investigational New Drug Application for SkinTE® in Chronic Cutaneous Ulcers

Life Sciences Times - 0
Pharma

FDA Approves Octapharma’s Octagam® 10% for Adult Dermatomyositis

Life Sciences Times - 0
Pharma

Circle Pharma Appoints Evelyn Wang, PhD as its Vice President, Translational Medicine

Life Sciences Times - 0
Pharma

MyMD Pharmaceuticals Announces New Data from Comparative Study on Lead Compound MYMD-1

Life Sciences Times - 0
Pharma

Philip Morris International Announces Agreement to Acquire Fertin Pharma

Life Sciences Times - 0
Pharma

Treatment With Hepcludex® (Bulevirtide) Was Shown to Achieve Significant Response in Chronic Hepatitis Delta Virus After 24 Weeks

Life Sciences Times - 0
Pharma

Glycomine Closes $68 Million Series B to Advance into Clinical Trials a Novel Treatment for PMM2-CDG, a Rare Glycosylation Disease

Life Sciences Times - 0
Pharma

Amalgam Rx™ Receives CE Mark for Basal Insulin Titration

Life Sciences Times - 0
Pharma

BeiGene Presents Long-Term Efficacy and Safety Results from Three Pivotal Trials of BRUKINSA

Life Sciences Times - 0
Pharma

U.S. Food and Drug Administration Approves New Formulation of Epclusa®, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C

Life Sciences Times - 0
1...909192...101Page 91 of 101

Most Read